文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Advances in technical methods and applications of subretinal injections in experimental animals.

作者信息

Song Chunyan, Ji Yuke, Wang Yun, Yang Weihua

机构信息

Shenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, China.

出版信息

Front Vet Sci. 2025 Apr 30;12:1574519. doi: 10.3389/fvets.2025.1574519. eCollection 2025.


DOI:10.3389/fvets.2025.1574519
PMID:40370828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12075335/
Abstract

The subretinal injection technique is an important intraocular drug delivery modality that allows access to the subretinal space to directly act on target cells or the administration of medications, markedly improving the therapeutic efficacy of ocular diseases. Subretinal injection in experimental animals is a commonly used manipulation method for investigating vitreoretinal diseases, particularly when gene therapy and cell therapy studies are involved. In this study, we conducted a systematic review on the injection methods, operation sites, post-injection indicators, as well as the progress and significance of subretinal injection in experimental animals, discussed and compared the advantages and disadvantages of the subretinal injection technique, summarized its specific application of subretinal injection in experimental animals, and explored the development and application of this new technology of subretinal injection, hoping to offer insights that may facilitate the further development of this technology.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/c5b195564419/fvets-12-1574519-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/336cca1d83ac/fvets-12-1574519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/19745d007117/fvets-12-1574519-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/c5b195564419/fvets-12-1574519-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/336cca1d83ac/fvets-12-1574519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/19745d007117/fvets-12-1574519-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/c5b195564419/fvets-12-1574519-g003.jpg

相似文献

[1]
Advances in technical methods and applications of subretinal injections in experimental animals.

Front Vet Sci. 2025-4-30

[2]
Subretinal Injection: A Review on the Novel Route of Therapeutic Delivery for Vitreoretinal Diseases.

Ophthalmic Res. 2017

[3]
How Advanced are Nanocarriers for Effective Subretinal Injection?

Int J Nanomedicine. 2024-9-10

[4]
Subretinal Injection Techniques for Retinal Disease: A Review.

J Clin Med. 2022-8-12

[5]
Biomechanical considerations for optimising subretinal injections.

Surv Ophthalmol. 2024

[6]
Feasibility of Direct Vitrectomy-Sparing Subretinal Injection for Gene Delivery in Large Animals.

Curr Eye Res. 2024-8

[7]
The Role of Subretinal Injection in Ophthalmic Surgery: Therapeutic Agent Delivery and Other Indications.

Int J Mol Sci. 2023-6-23

[8]
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study.

Lancet. 2024-4-20

[9]
Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats.

J Vis Exp. 2025-3-7

[10]
Effect of subretinal injection on retinal structure and function in a rat oxygen-induced retinopathy model.

Mol Vis. 2017-11-29

本文引用的文献

[1]
Biomechanical considerations for optimising subretinal injections.

Surv Ophthalmol. 2024

[2]
Techniques for subretinal injections in animals.

Vet Ophthalmol. 2025-3

[3]
Feasibility of Direct Vitrectomy-Sparing Subretinal Injection for Gene Delivery in Large Animals.

Curr Eye Res. 2024-8

[4]
Subretinal AAV delivery of RNAi-therapeutics targeting reduces choroidal neovascularization in a large animal model.

Mol Ther Methods Clin Dev. 2024-3-22

[5]
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study.

Lancet. 2024-4-20

[6]
CRISPR/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model.

Exp Biol Med (Maywood). 2023-10

[7]
GMP-grade human neural progenitors delivered subretinally protect vision in rat model of retinal degeneration and survive in minipigs.

J Transl Med. 2023-9-25

[8]
Soluble CX3CL1-expressing retinal pigment epithelium cells protect rod photoreceptors in a mouse model of retinitis pigmentosa.

Stem Cell Res Ther. 2023-8-21

[9]
Gene augmentation therapy to rescue degenerative photoreceptors in a Cwc27 mutant mouse model.

Exp Eye Res. 2023-9

[10]
The Role of Subretinal Injection in Ophthalmic Surgery: Therapeutic Agent Delivery and Other Indications.

Int J Mol Sci. 2023-6-23

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索